MediXall Group, Inc. (MDXL) financial statements (2021 and earlier)

Company profile

Business Address 2929 EAST COMMERCIAL BLVD
FT LAUDERDALE, FL 33308
State of Incorp. NV
Fiscal Year End December 31
SIC 4011 - Railroads, Line-Haul Operating (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 446202191115 0
Cash and cash equivalents 446202191115 0
Receivables  161    
Total current assets: 446362191115 0
Noncurrent Assets
Operating lease, right-of-use asset 113
Property, plant and equipment 221512   
Long-term investments and receivables     25 
Long-term investments     25 
Intangible assets, net (including goodwill) 357351164   
Intangible assets, net (excluding goodwill) 357351164   
Total noncurrent assets: 492367176 25 
TOTAL ASSETS: 938729368115250
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 161164321472292265
Accounts payable     63227
Accrued liabilities     22938
Other undisclosed accounts payable and accrued liabilities 161164321472  
Debt 71     
Due to related parties 26222272548401274
Other undisclosed current liabilities     334505
Total current liabilities: 4941865921,0211,0271,045
Noncurrent Liabilities
Long-term debt and lease obligation 46     
Operating lease, liability 46
Total noncurrent liabilities: 46     
Total liabilities: 5401865921,0211,0271,045
Stockholders' equity
Stockholders' equity attributable to parent 398543(225)(906)(1,002)(1,044)
Preferred stock 0000 1
Common stock 81695933838
Common stock, value, subscriptions    756  
Additional paid in capital 13,96610,7027,0524,0303,9973,607
Accumulated deficit (13,650)(10,229)(7,336)(5,695)(5,038)(4,689)
Total stockholders' equity: 398543(225)(906)(1,002)(1,044)
TOTAL LIABILITIES AND EQUITY: 938729368115250

Income statement (P&L) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Gross profit: 3222   
Operating expenses (3,424)(2,985)(1,663)(657)(349)(684)
Operating loss: (3,421)(2,983)(1,641)(657)(349)(684)
Net loss available to common stockholders, diluted: (3,421)(2,983)(1,641)(657)(349)(684)

Comprehensive Income ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss: (3,421)(2,983)(1,641)(657)(349)(684)
Comprehensive loss, net of tax, attributable to parent: (3,421)(2,983)(1,641)(657)(349)(684)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: